| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | S Chatterjee | |
| S E Bartlett | |||
| P2860 | cites work | Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior | Q22241964 |
| Neuropharmacology of alcohol addiction | Q22251110 | ||
| Mammalian nicotinic acetylcholine receptors: from structure to function | Q24647069 | ||
| Error monitoring using external feedback: specific roles of the habenular complex, the reward system, and the cingulate motor area revealed by functional magnetic resonance imaging | Q28206133 | ||
| Mecamylamine (Inversine): an old antihypertensive with new research directions | Q28206491 | ||
| Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes | Q28212546 | ||
| Recovery from DSM-IV alcohol dependence: United States, 2001-2002 | Q28236885 | ||
| Insensitivity to future consequences following damage to human prefrontal cortex | Q28245479 | ||
| Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation | Q28250054 | ||
| Neurokinin 1 receptor antagonism as a possible therapy for alcoholism | Q28268781 | ||
| Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid | Q28278033 | ||
| Nicotinic acetylcholine involvement in cognitive function in animals | Q28281303 | ||
| Cellular and molecular mechanisms of drug dependence | Q28283898 | ||
| A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition | Q28294356 | ||
| Neuronal nicotinic receptors: from structure to pathology | Q28302341 | ||
| Lateral habenula as a source of negative reward signals in dopamine neurons | Q28303742 | ||
| Distribution of nicotinic receptors in the human hippocampus and thalamus | Q28306933 | ||
| A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment | Q28324465 | ||
| Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms | Q28372016 | ||
| Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice | Q28506626 | ||
| Identification of four classes of brain nicotinic receptors using beta2 mutant mice | Q28510911 | ||
| Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei | Q28564628 | ||
| Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography | Q28581959 | ||
| Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization | Q28588299 | ||
| Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine | Q28589593 | ||
| Involvement of the alpha3 subunit in central nicotinic binding populations | Q28592088 | ||
| Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro | Q29040030 | ||
| Human neuronal nicotinic receptors | Q29397943 | ||
| The reinstatement model of drug relapse: history, methodology and major findings | Q29616241 | ||
| Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective | Q29619995 | ||
| Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking | Q30396291 | ||
| The genetic components of alcohol and nicotine co-addiction: from genes to behavior | Q30489302 | ||
| The alpha 3 subunit gene of the nicotinic acetylcholine receptor is a candidate gene for ethanol stimulation | Q30494943 | ||
| Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking | Q30502320 | ||
| Orbitofrontal cortex and human drug abuse: functional imaging | Q30588024 | ||
| Nicotinic modulation of neuronal networks: from receptors to cognition | Q30993631 | ||
| Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers | Q31874181 | ||
| Frontal lobe changes in alcoholism: a review of the literature | Q31961062 | ||
| Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. | Q33508060 | ||
| Cognitive impairments in abstinent alcoholics | Q33558187 | ||
| Varenicline reduces alcohol self-administration in heavy-drinking smokers | Q33825408 | ||
| Functional distribution of nicotinic receptors in CA3 region of the hippocampus | Q33856120 | ||
| Bupropion: a review of its use in the management of smoking cessation | Q33914387 | ||
| Nicotinic receptors at the amino acid level | Q33932170 | ||
| Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial | Q33997418 | ||
| Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis | Q34093476 | ||
| Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences | Q34126964 | ||
| The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences | Q34159445 | ||
| Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. | Q34165289 | ||
| Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells | Q34307351 | ||
| Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone | Q34330346 | ||
| Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. | Q34385923 | ||
| Co-occurring risk factors for alcohol dependence and habitual smoking. | Q34429837 | ||
| Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization | Q34459004 | ||
| Brain dopamine and reward | Q34498922 | ||
| Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation | Q34565766 | ||
| Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study | Q34608030 | ||
| Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. | Q34610366 | ||
| Efferent connections of the habenular nuclei in the rat | Q34638735 | ||
| Nicotine and neurodegeneration in ageing. | Q34674694 | ||
| Efferent connections of the substantia nigra and ventral tegmental area in the rat | Q34686077 | ||
| A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats | Q34822245 | ||
| Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence | Q34850154 | ||
| Structural and functional diversity of native brain neuronal nicotinic receptors | Q34983875 | ||
| Nicotinic receptor subtypes and cognitive function | Q35000331 | ||
| Shared genetic vulnerability in alcohol and cigarette use and dependence | Q35033752 | ||
| Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats | Q35151443 | ||
| Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence | Q35237992 | ||
| Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes | Q35609817 | ||
| Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion | Q35613704 | ||
| Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease | Q35626834 | ||
| The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: beta 4. | Q35792603 | ||
| Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task | Q35793657 | ||
| Nicotine increases alcohol self-administration in non-dependent male smokers | Q46627190 | ||
| 3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation | Q46711128 | ||
| Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence? | Q46722219 | ||
| A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. | Q46751109 | ||
| Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. | Q46850474 | ||
| Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment | Q46934887 | ||
| Intermittent presentations of ethanol sipper tube induce ethanol drinking in rats | Q46943120 | ||
| Antagonism of ethanol ataxia by intracerebellar nicotine: possible modulation by mouse cerebellar nitric oxide and cGMP. | Q46988351 | ||
| Purification of acetylcholine receptors from Torpedo claifornica electroplax by affinity chromatography | Q48014263 | ||
| Tolerance to and cross tolerance between ethanol and nicotine | Q48114475 | ||
| Alpha3beta4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons | Q48125195 | ||
| Encoding predicted outcome and acquired value in orbitofrontal cortex during cue sampling depends upon input from basolateral amygdala | Q48213029 | ||
| Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex | Q48217733 | ||
| The effect of drugs interacting with serotonergic 5HT3 and 5HT4 receptors on morphine place conditioning | Q48229117 | ||
| Ethanol-nicotine interactions at alpha-bungarotoxin-insensitive nicotinic acetylcholine receptors in rat cortical neurons | Q48243202 | ||
| Rodent lines selected for factors affecting alcohol consumption | Q48244134 | ||
| Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats | Q48264505 | ||
| Gamma-aminobutyric acid and alcohol actions: neurochemical studies of long sleep and short sleep mice. | Q48275382 | ||
| Suppression of ethanol-induced locomotor stimulation by GABA-like drugs | Q48343565 | ||
| Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine | Q48346302 | ||
| Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning | Q48394260 | ||
| The topographic order of inputs to nucleus accumbens in the rat. | Q48446502 | ||
| Ethanol-induced locomotor activity: involvement of central nicotinic acetylcholine receptors? | Q48447554 | ||
| Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats | Q48453318 | ||
| Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype | Q48488509 | ||
| Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin | Q48491137 | ||
| Decision-making deficits in drug addiction | Q48498708 | ||
| Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine | Q48593995 | ||
| Retrograde HRP tracing combined with a pharmacohistochemical method for GABA transaminase for the identification of presumptive GABAergic projections to the habenula | Q48656053 | ||
| Alcohol habits in a suburban male cohort | Q48685572 | ||
| Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. | Q48739569 | ||
| A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice | Q48862177 | ||
| A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice. | Q48862204 | ||
| The effect of chronic ethanol administration of high affinity 3H-nicotinic binding in rat brain | Q48888581 | ||
| Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes | Q48920241 | ||
| Ethanol-nicotine interactions in long-sleep and short-sleep mice | Q48924760 | ||
| Long-term ethanol and nicotine treatment elicit tolerance to ethanol | Q48925814 | ||
| Alterations in opiate receptor function after chronic ethanol exposure | Q48930231 | ||
| Hippocampal-dependent learning and experience-dependent activation of the hippocampus are preferentially disrupted by ethanol | Q48932833 | ||
| Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor | Q48985007 | ||
| Effect of intraventricular injections of dihydro-beta-erythroidine (DH beta E) on spatial memory in the rat. | Q49019107 | ||
| Thirty-two years of selection of rats by ethanol preference: UChA and UChB strains. | Q49116888 | ||
| Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes | Q49158173 | ||
| Alterations in taste reactivity to alcohol in rats given continuous alcohol access followed by abstinence | Q50119955 | ||
| Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. | Q50918228 | ||
| Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. | Q51094841 | ||
| Ondansetron alters human alcohol intoxication. | Q51110828 | ||
| Development of novel medications for drug addiction. The legacy of an African shrub. | Q51389922 | ||
| Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor. | Q51643447 | ||
| The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. | Q51972018 | ||
| Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. | Q44234396 | ||
| Effect of Ethanol on ?-Aminobutyric Acid and Glycine Receptor-Coupled Cl?Fluxes in Rat Brain Synaptoneurosomes | Q44242940 | ||
| Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study | Q44268856 | ||
| Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats | Q44283841 | ||
| Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice | Q44292703 | ||
| Importance of delta opioid receptors in maintaining high alcohol drinking | Q44333918 | ||
| A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients | Q44341917 | ||
| Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. | Q44345785 | ||
| Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress | Q44351675 | ||
| Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors | Q44410731 | ||
| Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers | Q44453598 | ||
| Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects | Q44491703 | ||
| A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence | Q44524349 | ||
| Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials. | Q44529153 | ||
| Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors. | Q44588624 | ||
| BIG news in alcohol addiction: new findings on growth factor pathways BDNF, insulin, and GDNF. | Q44592016 | ||
| Dopamine activity in the nucleus accumbens during consummatory phases of oral ethanol self-administration | Q44628784 | ||
| Interaction of the Nicotinic Cholinergic System with Ethanol Withdrawal | Q44650592 | ||
| Nicotine enhances contextual fear conditioning and ameliorates ethanol-induced deficits in contextual fear conditioning | Q44692796 | ||
| Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells | Q44722648 | ||
| The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis | Q44743703 | ||
| Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness | Q44834253 | ||
| An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions | Q44927943 | ||
| Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex | Q44989553 | ||
| Interactions between low concentrations of ethanol and nicotine on firing rate of ventral tegmental dopamine neurones | Q44994521 | ||
| Ethanol operant self-administration in rats is regulated by adenosine A2 receptors | Q45057379 | ||
| Long-term heavy marijuana users make costly decisions on a gambling task | Q45068087 | ||
| Nicotine inhibits ethanol-induced toxicity in cultured cerebral cortical cells | Q45151489 | ||
| Alcoholic subtypes: are two sufficient? | Q45177868 | ||
| Nicotine acetylcholine receptors and neuropsychiatric disorders | Q45206659 | ||
| Mecamylamine and ethanol preference in healthy volunteers | Q45227006 | ||
| Age at smoking onset and its association with alcohol consumption and DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey | Q45240544 | ||
| Mecamylamine increases nicotine preference and attenuates nicotine discrimination | Q45326860 | ||
| Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition | Q45399038 | ||
| Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications. | Q45987186 | ||
| Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link? | Q46026429 | ||
| Reduced affective symptoms during tobacco dependence treatment with varenicline. | Q46026431 | ||
| Studies linking smoking-cessation drug with suicide risk spark concerns | Q46091854 | ||
| Smoking cessation with varenicline: a suicidal fatality | Q46110792 | ||
| The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system | Q46173380 | ||
| Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior | Q46261665 | ||
| The risk-benefit balance of varenicline for smoking cessation | Q46402917 | ||
| Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol? | Q46498223 | ||
| In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine | Q46502561 | ||
| Varenicline reduced smoking behaviour in a mentally ill person | Q46533461 | ||
| Voluntary ethanol intake increases extracellular acetylcholine levels in the ventral tegmental area in the rat. | Q46618419 | ||
| Impairment on a simulated gambling task in long-term abstinent alcoholics | Q35793704 | ||
| Subtypes of alcohol dependence in a nationally representative sample | Q36169430 | ||
| Acamprosate in the treatment of alcohol dependence | Q36273459 | ||
| Combining treatments for alcoholism: why and how? | Q36285441 | ||
| Behavioral and neural mechanisms of compulsive drug seeking | Q36323765 | ||
| Brain nicotinic acetylcholine receptors: native subtypes and their relevance. | Q36550823 | ||
| The alcohol-preferring P rat and animal models of excessive alcohol drinking | Q36589453 | ||
| Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system | Q36607367 | ||
| The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions | Q36724397 | ||
| Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice | Q36746829 | ||
| Alcohol's actions on neuronal nicotinic acetylcholine receptors. | Q36764756 | ||
| Variants in nicotinic receptors and risk for nicotine dependence | Q36952598 | ||
| A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence | Q36972064 | ||
| Varenicline augmentation in depressed smokers: an 8-week, open-label study | Q37025397 | ||
| Nicotinic receptor gene variants influence susceptibility to heavy smoking | Q37037625 | ||
| Chromosome 15q25.1 genetic markers associated with level of response to alcohol in humans | Q37068584 | ||
| Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials. | Q37093531 | ||
| Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline | Q37160367 | ||
| Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation | Q37189749 | ||
| Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes | Q37219461 | ||
| Effects of alcoholism severity and smoking on executive neurocognitive function | Q37325216 | ||
| Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task | Q37399346 | ||
| Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness | Q37454118 | ||
| nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. | Q37465460 | ||
| Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors | Q37672083 | ||
| Alcohol or tobacco research versus alcohol and tobacco research | Q37909088 | ||
| Behavioral aspects of alcohol-tobacco interactions. | Q37920115 | ||
| Nicotine receptors in the mammalian brain | Q37942463 | ||
| Structural and functional heterogeneity of nicotinic receptors. | Q37957234 | ||
| Alcohol challenge with sons of alcoholics: a critical review and analysis | Q38018987 | ||
| Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. | Q38405712 | ||
| Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. | Q38407349 | ||
| Abnormal associative encoding in orbitofrontal neurons in cocaine-experienced rats during decision-making | Q38572234 | ||
| Ethanol and the nervous system | Q38674639 | ||
| What is the nature of mecamylamine's antagonism of the central effects of nicotine? | Q38721802 | ||
| Tobacco, alcohol, and caffeine use: a review of their interrelationships | Q40226607 | ||
| Impaired decision-making in psychopathic heroin addicts | Q40294554 | ||
| The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex | Q40328589 | ||
| Drinking trajectories from adolescence to the mid-forties among alcohol dependent males. | Q40352860 | ||
| The Diversity of Neuronal Nicotinic Acetylcholine Receptors | Q40485774 | ||
| Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. | Q40543258 | ||
| Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration | Q40743432 | ||
| Functional diversity of neuronal nicotinic acetylcholine receptors | Q40783662 | ||
| Alcohols and neurotransmitter gated ion channels: past, present and future | Q40882361 | ||
| Central cholinergic systems and cognition | Q41359581 | ||
| Pharmacology of neuronal nicotinic acetylcholine receptor subtypes | Q41478089 | ||
| Conceptualizing and scaling the developmental structure of behavior disorder: the Lifetime Alcohol Problems Score as an example | Q41513627 | ||
| Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies | Q41574239 | ||
| Contribution of nicotinic acetylcholine receptors containing the beta 2-subunit to the behavioural effects of nicotine | Q41655449 | ||
| Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon | Q41696943 | ||
| Neuropsychological correlates of adolescent substance abuse: four-year outcomes | Q41702403 | ||
| Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila | Q41723276 | ||
| Involvement of the entopeduncular nucleus and the habenula in methamphetamine-induced inhibition of dopamine neurons in the substantia nigra of rats | Q41809248 | ||
| Dopaminergic neurons in the ventral tegmental area of C57BL/6J and DBA/2J mice differ in sensitivity to ethanol excitation | Q42491433 | ||
| Increased ethanol excitation of dopaminergic neurons of the ventral tegmental area after chronic ethanol treatment | Q42524676 | ||
| Ethanol enhances GABA-induced 36Cl-influx in primary spinal cord cultured neurons | Q42525667 | ||
| Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder | Q42613652 | ||
| Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats | Q43146230 | ||
| Demonstration of functional alpha4-containing nicotinic receptors in the medial habenula | Q43178185 | ||
| Varenicline gets stronger warnings about psychiatric problems, vehicle crashes | Q43286222 | ||
| Selection of a single ethanol test solution in free-choice studies with animals | Q43493931 | ||
| Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition | Q43549130 | ||
| Nicotine-induced behavioral disinhibition and ethanol preference correlate after repeated nicotine treatment | Q43574365 | ||
| Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial | Q43626111 | ||
| Chronic infusion of nicotine can increase operant self-administration of alcohol | Q43668144 | ||
| Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons | Q43823129 | ||
| Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. | Q43826495 | ||
| Classification and course of alcohol problems among adolescents in addictions treatment programs | Q43848007 | ||
| Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. | Q43893915 | ||
| Autoshaping of ethanol drinking: an animal model of binge drinking | Q43931155 | ||
| Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice | Q43937577 | ||
| Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol | Q43940291 | ||
| Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens | Q43940320 | ||
| Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents | Q43970776 | ||
| Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors | Q44080843 | ||
| Effects of hypothalamic stimulation, acclimation and periodic withdrawal on ethanol consumption | Q44096038 | ||
| Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. | Q44185954 | ||
| Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell | Q80767727 | ||
| Genetic selection for voluntary alcohol consumption in the albino rat | Q81068915 | ||
| Nicotinic acetylcholine receptors: an overview on drug discovery | Q83588847 | ||
| Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. | Q52042144 | ||
| Decision-making biases, antisocial personality, and early-onset alcoholism. | Q52166375 | ||
| Sex differences in the acute effects of cigarette smoking on the reinforcing value of alcohol. | Q52168221 | ||
| Involvement of nicotinic receptors in alcohol self-administration. | Q52170503 | ||
| Ethanol directly excites dopaminergic ventral tegmental area reward neurons. | Q52172659 | ||
| Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. | Q52260802 | ||
| Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial. | Q52272367 | ||
| Chronic tolerance and sensitization to alcohol in sons of alcoholics: II. Replication and reanalysis. | Q52277478 | ||
| Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. | Q52290066 | ||
| Ethanol intake during schedule-induced polydipsia. | Q52326279 | ||
| Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. | Q54007988 | ||
| Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, alpha 3 beta 4, expressed in transfected eucaryotic cells. | Q54067928 | ||
| Ethanol inhibits NMDA-activated ion current in hippocampal neurons | Q56226684 | ||
| Pharmacological and null mutation approaches reveal nicotinic receptor diversity | Q60339402 | ||
| Purification of acetylcholine receptor from Torpedo californica and its incorporation into phospholipid vesicles | Q66851493 | ||
| Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor | Q67258497 | ||
| Temporal relationship of the induction of tolerance and physical dependence after continuous intoxication with maximum tolerable doses of ethanol in rats | Q67530902 | ||
| The limited access paradigm: description of one method | Q67569673 | ||
| Naltrexone and coping skills therapy for alcohol dependence. A controlled study | Q67587951 | ||
| Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons | Q67697982 | ||
| Effects of periodic withdrawal on ethanol and saccharin selection in rats | Q67841726 | ||
| [3H]cytisine binding to nicotinic cholinergic receptors in brain | Q68182225 | ||
| The course of alcoholism. Long-term prognosis in different types | Q68257500 | ||
| A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques | Q68700956 | ||
| Ethanol increases agonist affinity for nicotinic receptors from Torpedo | Q69404079 | ||
| Nicotine-induced potentiation of ethanol discrimination | Q69499579 | ||
| Voluntary ethanol intake in rats following exposure to ethanol on various schedules | Q69513977 | ||
| Acute and chronic tolerance to nicotine measured by activity in rats | Q69557254 | ||
| Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats | Q70398932 | ||
| Inheritance of alcohol abuse. Cross-fostering analysis of adopted men | Q70863106 | ||
| Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat | Q71139843 | ||
| Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol | Q71774107 | ||
| Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs | Q71776637 | ||
| Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats | Q71854848 | ||
| Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment | Q71865726 | ||
| Self-stimulation of the habenular complex in the rat | Q72098570 | ||
| The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine | Q72723449 | ||
| Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats | Q73187433 | ||
| Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats | Q73705458 | ||
| A comparison of sustained-release bupropion and placebo for smoking cessation | Q73804709 | ||
| Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence | Q73837327 | ||
| Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers | Q74072253 | ||
| Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm | Q77402421 | ||
| The effects of the GABA(B) agonist baclofen on the temporal and structural characteristics of ethanol intake | Q77409225 | ||
| Common genetic vulnerability for nicotine and alcohol dependence in men | Q77987975 | ||
| Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol | Q79786575 | ||
| P433 | issue | 1 | |
| P921 | main subject | alcohol consumption | Q2647488 |
| P304 | page(s) | 60-76 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | CNS and Neurological Disorders | Q15724632 |
| P1476 | title | Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders | |
| P478 | volume | 9 |
| Q28068256 | A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction |
| Q36420087 | Accentuating effects of nicotine on ethanol response in mice with high genetic predisposition to ethanol-induced locomotor stimulation |
| Q27345275 | Alcohol and nicotine interactions: pre-clinical models of dependence |
| Q30447847 | Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity |
| Q33668283 | CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women |
| Q36372867 | Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse |
| Q52639267 | Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs. |
| Q47275723 | Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial |
| Q34940888 | Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization |
| Q47311042 | Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats. |
| Q38824915 | Interactions between nicotine and drugs of abuse: a review of preclinical findings |
| Q37404222 | Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems. |
| Q47667884 | Mecamylamine treatment for alcohol dependence: a randomized controlled trial. |
| Q27690692 | Medications for unhealthy alcohol use: across the spectrum |
| Q28382954 | MicroRNAs in Neurotoxicity |
| Q36581622 | Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening. |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q37722622 | Nicotine administration in the cholinergic basal forebrain increases alcohol consumption in C57BL/6J mice. |
| Q47960292 | Nicotine administration in the wake-promoting basal forebrain attenuates sleep-promoting effects of alcohol |
| Q34415917 | Nicotine infusion in the wake-promoting basal forebrain enhances alcohol-induced activation of nucleus accumbens. |
| Q24234860 | Nicotine receptor partial agonists for alcohol dependence |
| Q26472086 | Nicotine receptor partial agonists for alcohol dependence |
| Q35960331 | Nicotinic Mechanisms Modulate Ethanol Withdrawal and Modify Time Course and Symptoms Severity of Simultaneous Withdrawal from Alcohol and Nicotine |
| Q28087047 | Nicotinic receptor modulation to treat alcohol and drug dependence |
| Q36011376 | Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder. |
| Q34661812 | Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats |
| Q37708082 | Pharmacological approaches to reducing craving in patients with alcohol use disorders |
| Q52316684 | Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management. |
| Q36039402 | Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. |
| Q36581617 | Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism |
| Q90452281 | Reduced expression of ethanol sensitization by α3β4 nicotinic acetylcholine receptors in DBA/2J mice |
| Q37094759 | The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses |
| Q37404736 | The effects of varenicline on alcohol seeking and self-administration in baboons. |
| Q41566428 | The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in rats |
| Q47550611 | The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption |
| Q35788371 | The role of varenicline on alcohol-primed self-administration and seeking behavior in rats |
| Q37514878 | The α5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice |
| Q92070044 | UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats |
| Q38129470 | Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction? |
| Q33929766 | Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens |
| Q43188062 | Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats. |
| Q35046256 | Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats |
Search more.